老年重症心力衰竭急诊内科治疗的临床分析

Clinical analysis of elderly patients with severe heart failure treated in the emergency internal medicine

为探讨老年重症心力衰竭急诊内科治疗的临床效果,随机抽取我院在2016年1月—2017年5月收治的80例老年重症心力衰竭患者的临床资料进行回顾性分析,根据患者治疗方法的不同将本组患者分为两组,对照组(40例)和观察组(40例),对照组给予常规治疗,观察组在常规治疗的基础上给予厄贝沙坦氢噻嗪治疗和美托洛尔治疗。对照组效果:优22例,良8例,差10例;观察组效果:优32例,良7例,差1例,观察组患者的治疗效果明显优于对照组,差异显著,具有统计学意义,P<0.05。对照组5例出现不良反应,观察组无一例不良反应,观察组效果明显高于对照组,差异显著,具有统计学意义,P<0.05。说明厄贝沙坦氢噻嗪和美托洛尔治疗老年重症心力衰竭,疗效确切,临床效果较好。

The elderly patients with severe heart failure of the emergency internal medicine in our hospital were randomly selected in the clinical data of 80 cases from January 2016 to May 2017,according to the different treatment methods for patients with these patients were divided into two groups,the control group(40 cases) and observation group(40 cases),the control group was given routine treatment,the observation group in the conventional treatment based on the given irbesartan hydrochlorothiazide treatment and metoprolol in the treatment of hydrogen.Control group:excellent 22 cases,good in 8 cases,poor in 10 cases;the observation group:excellent 32 cases,good in 7 cases,poor in 1 cases,the curative effect of observation group was significantly better than the control group,the difference was significant,with statistical significance,P<0.05.The control group of 5 cases of adverse reactions,the observation group with no adverse reactions,the effect of the observation group was significantly higher than the control group,the difference was significant,with statistical significance,P<0.05.Irbesartan hydrochlorothiazide and metoprolol in the treatment of elderly patients with severe heart failure has curative effect with good clinical effect.